Search by Drug Name or NDC

NDC 64980-0343-50 Clopidogrel 75 mg/1 Details

Clopidogrel 75 mg/1

Clopidogrel is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Rising Pharma Holdings, Inc.. The primary component is CLOPIDOGREL BISULFATE.

MedlinePlus Drug Summary

Clopidogrel is used alone or with aspirin to prevent serious or life-threatening problems with the heart and blood vessels in people who have had a stroke, heart attack, or severe chest pain. This includes people who have percutaneous coronary intervention (PCI; angioplasty; a type of heart surgery) that may involve inserting coronary stents (metal tubes surgically placed in clogged blood vessels to improve blood flow) or who have coronary artery bypass grafting (CABG; a type of heart surgery). Clopidogrel is also used to prevent serious or life-threatening problems with the heart and blood vessels in people who have peripheral arterial disease (poor circulation in the blood vessels that supply blood to the legs). Clopidogrel is in a class of medications called antiplatelet medications. It works by preventing platelets (a type of blood cell) from collecting and forming clots that may cause a heart attack or stroke.

Related Packages: 64980-0343-50
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Clopidogrel

Product Information

NDC	64980-0343
Product ID	64980-343_35102b70-c689-4975-a3cc-5ae7b5a54810
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Clopidogrel
Proprietary Name Suffix	n/a
Non-Proprietary Name	Clopidogrel Bisulfate
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, FILM COATED
Route	ORAL
Active Ingredient Strength	75
Active Ingredient Units	mg/1
Substance Name	CLOPIDOGREL BISULFATE
Labeler Name	Rising Pharma Holdings, Inc.
Pharmaceutical Class	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA090540
Listing Certified Through	2024-12-31

Package

NDC 64980-0343-50 (64980034350)

Pricing Information	N/A
NDC Package Code	64980-343-50
Billing NDC	64980034350
Package	500 TABLET, FILM COATED in 1 BOTTLE (64980-343-50)
Marketing Start Date	2012-05-17
NDC Exclude Flag	N